Gilead says remdesivir shows improvement in COVID-19 patients when used early

[jmyrlefuller]

https://www.reuters.com/article/us-health-coronavirus-gilead-remdesivir/gileads-remdesivir-meets-main-goal-of-trial-in-covid-19-patients-idUSKBN22B1T9

Gilead Sciences Inc’s experimental antiviral drug remdesivir helped improve symptoms in COVID-19 patients who were given the drug early than among those who were treated later, the company said.

The closely-watched drug has moved markets in the past few weeks and on Wednesday broader markets once again rose on the data and Gilead shares also jumped 9%.

In Gilead’s study, 62% of patients treated early were discharged from the hospital, compared with 49% of patients who were treated late, the company said.

(excerpt)